Latest Sales Growth News

Immuron Limited has inked an exclusive US distribution deal for PROIBS®, a European-certified medical device targeting abdominal discomfort, marking a key step in its digestive health portfolio growth.

Endeavour Group confirms a fully franked dividend of AUD 0.012 per share for the six months ending June 2026, offering shareholders a choice of payment in Australian or New Zealand dollars based on their registered bank accounts.

MaxiPARTS has received a $2.50 per share indicative cash offer from Ares Management Asia, representing a substantial premium and triggering a four-week exclusivity period for due diligence. Concurrently, MaxiPARTS is acquiring Air Brake Systems for $11.2 million, a move expected to boost earnings and expand its product range.

Yowie Group Limited cut its net loss to US$0.20 million in FY26 despite a 27.1% drop in revenue, driven by cost cuts, loan impairment reversals, and new product launches including the Yowie x NBA series.

Collins Foods posted record FY26 revenue and underlying profit, exited Taco Bell to focus on KFC growth, and outlined ambitious expansion plans in Germany and Australia.

Osteopore Limited’s half-year results show an 8% revenue drop driven by currency effects, while losses widen 14% as the company invests heavily in product development and market growth.

Activeport Group Ltd’s FY26 results show a 36% revenue decline to $6.15 million and a net loss of $14.7 million, driven by strategic shifts towards recurring software revenue and AI infrastructure orchestration. The company launched its own national network in Australia and expanded internationally with new subsidiaries and leadership hires.

Oliver's Real Food swung to a statutory profit of $598k in FY2026, reversing a $2.91 million loss a year earlier, driven by store closures and cost discipline. Despite an 8% revenue drop, EBITDAI surged 36.8%, and the company kicked off FY27 with encouraging sales and earnings growth.

Advance ZincTek posted an 11% rise in FY26 profit before tax to $2.247 million on 12.6% higher sales, driven by AI integration and US market strength. The company is set to enter residential battery manufacturing in FY27, leveraging its zinc oxide expertise.

Clever Culture Systems expanded its pharmaceutical customer base to eight in FY26, placing 11 APAS Independence instruments and completing its product offering with a contact plate module. Despite a $2.24 million net loss, the company expects meaningful sales growth in FY27 backed by a robust pipeline and disciplined financial management.

archTIS Limited’s FY2026 results reveal a 120% surge in sales revenue to $13.35 million, fueled by the Spirion acquisition, yet losses ballooned to $16.3 million reflecting higher operating costs and integration expenses.

Novatti has swung to a positive EBITDA of $2.0 million in FY26, driven by strategic refocusing on its core Payments AU/NZ business despite a 40.7% revenue decline and loss of control over AUDC.